How To Increase Enrollment In Trials

Slides:



Advertisements
Similar presentations
Antiplatelet Therapy in the Catheterization Laboratory
Advertisements

William C. Cushman, MD, FACP, FAHA Veterans Affairs Medical Center, Memphis, TN For The ACCORD Study Group.
Rethinking Lower Blood Pressure Goals for Diabetic Patients with Coronary Artery Disease – Findings from the INternational VErapamil SR – Trandolapril.
Randall M. Zusman, MD Associate Professor of Medicine
BUY Recommendation: Gilead Sciences (GILD). Company Overview Gilead Sciences, Inc. is a research-based biopharmaceutical company found in 1987 that discovers,
“ Linking Blood Pressure and Cardiovascular Health” Welcome We invite you to explore what a membership in the American Society of Hypertension, Inc. (ASH)
PubMed was searched for randomized clinical trials published between 2007 and 2012 in the New England Journal of Medicine (NEJM) Trials were included if.
Marketing to Doctors – Payments for Loyalty Julie Brill Assistant Attorney General Vermont Attorney General ’ s Office Montpelier,
PRSA Student of the Year Competition. Introduction I approached this project as a patient looking for information on community service programs. By surveying.
Paradise Senior Health Center A Hospital-Based Clinic of Paradise Valley Hospital.
Beth Israel Deaconess Medical Center Harvard Medical School Beth Israel Deaconess Medical Center Harvard Medical School Tablets in Healthcare: Not Just.
Conclusion The fair agreement between both the sites and the ACL and the sites and CEC emphasizes the need to review all potential events. There is only.
Poster Title Angiographic Validation of the American College of Cardiology Foundation-The Society of Thoracic Surgeons Collaboration on the Comparative.
August 22, 2002 THE HIPAA COLLOQUIUM at Harvard University A. John Blair, III, MD Chairman and Chief Executive Officer Taconic IPA, Inc. Fishkill, NY HIPAA.
2014. Diamond Members  Alexion  Bristol Myers Squibb  Cardinal Health  Eisai, Inc.  Foundation Medicine  Genomic Health  McKesson  MedImmune.
Statewide campaign to educate patients and physicians on important health topics: Choosing Wisely® ER is for Emergencies campaign Palliative care and end.
How to Find and Access Clinical Trials New Treatments, No Tricks A Seminar on Minority Participation in Clinical Trials June 15, 2010.
How Much AF is Too Much AF? Do I Initiate Anticoagulation Based on AF Detected on Device Monitoring? Kenneth W. Mahaffey, MD, FACC Professor of Medicine,
Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
A “Back of the Envelope” Assessment of the Potential Cost Effectiveness of Dabigatran (Pradaxa) in Non- Valvular Atrial Fibrillation C. Michael Gibson,
Walk National Conference Marketing on a Shoestring Budget From the 2008 Walk Conference.
Healthcare Club Lunch & Learn: Pharma & Med Device August 24 th, 2015.
Managing Patients Who Cannot Take Anticoagulants Kenneth W. Mahaffey, MD, FACC Professor of Medicine, Cardiology Faculty Associate Director, DCRI Director,
+ Role of Industry in Clinical Care, Research, and Education.
1 ExTRACT-TIMI 25 : New Data Elliott M. Antman, MD This presentation reflects the views of the presenter and does not necessarily reflect the views of.
The Risk of CV Events for Patients Treated with Clopidogrel or Prasugrel in Combination with a Proton Pump Inhibitor Results from the TRITON-TIMI 38 Trial.
Trends in the Quality of Care of Patients with Acute Myocardial Infarction: The National Registry of Myocardial Infarction from 1990 to 2006 Bimal R. Shah,
Marketing Strategies for Telemedicine. Who Needs Telemedicine? o Patients who cannot find care in their community o Patients with conditions that make.
2 Is the #1 geo-targeted digital media company in the world Operates more than 500 city specific healthcare websites: –i.e.
© Copyright 2002 Frost & Sullivan. All Rights Reserved. U.S. Lipid Regulators Markets New Clinical Trials Should Spark Interest in Lipid Regulators "A.
VIVA Health, Inc. Health Plan & Medical Home Benefit Information Session.
ClinicalTrialResults.org Overview 4:10 – 4:15 pm Introductions C. Michael Gibson, MS, MD 4:15 – 4:30 pm Clinical Trial Results.org Overview C. Michael.
Challenges with Drug Administration Optimal Loading Dose and Delivery of P2Y12 Inhibitors: Should the Loading Dose Be Crushed? Dominick J. Angiolillo,
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Genitourinary Drugs Market Share, Segmentation, Report 2024.
Global Antithrombotic Drugs Market Primary Research, Risk Analysis, Product Research, Trends and Forecast by 2022 Phone No.: +1 (214) id:
Global Orphan Drug Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Phone No.: +1 (214) id:
VCU Pauley Heart Center:
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
Public Awareness: Empowering Consumers to Seek Certified Professionals
C. Michael Gibson, M.S., M.D. Harvard Medical School
Impact of Radial Access on Bleeding
Dominick J. Angiolillo, MD, PhD, FACC, FESC, FSCAI
Harvard Medical School C. Michael Gibson, M.S., M.D.
Clinical impact and predictors of complete ST-segment resolution after primary percutaneous coronary intervention: a subanalysis of the ATLANTIC Trial.
ROMANIAN CYSTIC FIBROSIS
Telemedicine To Detect Recurrent MI
Laura Mauri, MD, MSc Brigham and Women’s Hospital
Conflict of Interest Disclosure
Conflict of Interest Disclosure
The TREAT Study: Can Devices Lower Bleeding Rates?
Surrogate Endpoints Laura Mauri, MD, MSc Brigham and Women’s Hospital
Antidiabetics Market share to grow at 10.5% CAGR from 2016 to 2024
Pathways in Anticoagulation
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Over-the-Counter (OTC) Drugs.
By: Resource Development
Amnesty International
Stefan Gijssels, Janssen Pharmaceutica
The ANTARCTIC investigators
Jack Kavanaugh is internationally recognized doctor and businessman who has been involved in medical and science technology companies.
Grant Transparency and Medical Device Companies
Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD)
That Help Your Registry Grow With Participating Providers
Conflicts of Interest In the past 2 years I have been an employee of:
Canada Cardiovascular Prosthetic Devices Market Outlook to 2020
on Behalf of the COGENT Investigators
Conflict of Interest Disclosure
That Help Your Registry Grow With Participating Providers
Denmark Leads the Way In IT and Patient-Centered Primary Care 2006: An Example of High Performance Highest public satisfaction with health system among.
Successful Financing Strategies to Capitalize RHIOs
Causes and predictors of short, intermediate and long-term mortality in patients with coronary artery disease M. Zeitouni, N. Procopi, O. Barthélémy, Q.
Presentation transcript:

How To Increase Enrollment In Trials C. Michael Gibson, M.S., M.D. Chief, Clinical Research, Beth Israel Deaconess CV Division Chairman, PERFUSE Study Group Chairman of the Board of WikiDoc Foundation, www.wikidoc.org The World’s Open Source Textbook of Medicine Viewed 150 Million Times Annually Harvard Medical School

C. Michael Gibson, MD Consulting: Bristol-Myers Squibb Daiichi Sankyo Eli Lilly and Company Portola Pharmaceuticals, Inc. St. Jude Medical, Inc. Cytori Therapeutics The Medicines Company

C. Michael Gibson, MD Grant Support: Bayer Corporation, Angel Medical Systems, Inc., Atrium Medical Corporation, Ikaria, Inc., Lantheus Medical Imaging, Portola Pharmaceuticals, Inc., St. Jude Medical, Inc., Genentech, Inc., Stealth Peptides, Inc., Volcano Therapeutics, Inc, Johnson and Johnson, Walk Vascular, Merck and Company, Inc. and Sanofi-Aventis

C. Michael Gibson, MD Honoraria: Merck and Company, Inc. Regado Bio-Sciences Baxter International, Inc. Sanofi-Aventis Cardiovascular Research Foundation Consensus Medical Communications

Patient Based Strategies Increase awareness of the trial via: In-Hospital flyers Out patient clinic flyers Local radio: disease state pieces, interviews Local TV: disease state pieces, special interest stories Hospital TV Local newspaper: advertisements, disease state pieces, interviews Targeted email campaigns Billboards Hospital portal Dedicated trial website with appropriate tags & SEO Twitter You Tube interviews with appropriate tags Material must be approved by the IRB!

Strategies You Cannot Use You cannot lead patients to believe that there is a benefit to them personally from participating in the study Provide any monetary incentive to referring doctors (finders fee) You cannot provide any monetary incentive to patients for their participation You can obtain IRB approval to reimburse patients for travel expenses and parking expenses

Healthcare Provider Based Strategies Increase awareness of the trial via: Same as patient based strategies Grand rounds Morning report with housestaff Targeted email strategies Physician blog Letters via snail mail Breakfast / lunch to discuss trial with MDs and RNs Electronic medical record prompts

Strategies You Cannot Use Provide any monetary incentive to referring doctors (finders fee)

Use Of Social Media To Lead Trials